文献速递主动脉疾病颈动脉与弓上血管

应用原位激光开窗行主动脉弓腔内修复的早期与中期结局

Early and Midterm Outcomes of Endovascular Aortic Arch Repair Using In Situ Laser Fenestration.
PubMed 文献 · J Endovasc Ther · 2024-02-26

该单中心回顾性研究纳入2017年4月1日至2023年1月31日连续30例接受原位激光开窗胸主动脉腔内修复(LFTEVAR)的主动脉弓病变患者,比较早期(2017-2019)与晚期(2020-2023)经验。技术成功率93%,术后卒中3例(10%),其中1例为大卒中(3.3%),30天死亡率为13.5%,随访死亡率为15.3%。早期与晚期经验组结局无统计学显著差异。

要点

  • 30例LFTEVAR患者技术成功率93%,术后卒中3例(10%),其中大卒中1例(3.3%)。
  • 30天死亡率为13.5%,随访死亡率为15.3%,中位随访12个月(范围1-48个月)。
  • 早期(2017-2019)与晚期(2020-2023)经验组结局无统计学显著差异。

核心结论

  • 在有经验的主动脉中心,LFTEVAR治疗主动脉弓病变与较低的早期死亡率和卒中率相关。
  • 对于被认为不适合开放修复的患者,LFTEVAR是一种安全有效的治疗选择。

研究设计与样本

  • 遵循STROBE声明的单中心回顾性分析,数据来自前瞻性收集的单主动脉中心数据库。
  • 纳入2017年4月1日至2023年1月31日连续30例因主动脉弓病变接受LFTEVAR的患者。
  • 队列按早期(2017-2019)与晚期(2020-2023)经验二分比较。

主要发现

  • 30例患者中男性63.3%,平均年龄69.8±9.6岁,21.4%表现为主动脉破裂。
  • 主动脉弓部动脉瘤为最常见病变(53.3%)。
  • 共重建40支目标血管,包括19支左锁骨下动脉(47.5%)和17支左颈总动脉(42.5%)。
  • 10例患者行双开窗;近端锚定区为Ishimaru 0区5例(16.7%)、1区13例(43.3%)。
  • 技术成功率93%;无脊髓缺血记录;术后卒中3例(10%),其中大卒中1例(3.3%)。

临床怎么用

  • 作者认为,对于被认为不适合开放修复的患者,LFTEVAR是一种安全有效的治疗选择。
  • 作者指出,要在这些解剖条件复杂的高危患者中获得可接受的结局,必须充分具备复杂腔内主动脉修复的经验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The aim of this study is to present single-center outcomes in patients treated with in situ laser fenestration thoracic endovascular aortic repair (LFTEVAR) for various aortic arch pathologies and assess the impact of increasing experience. METHODS: The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement was followed. A retrospective analysis of prospectively collected single aortic center data was conducted, including baseline information and peri- and post-operative outcomes of consecutive patients managed with LFTEVAR for aortic arch pathologies. Patients were enrolled from April 1, 2017 to January 31, 2023. The cohort was dichotomized to compare early (2017-2019) and late experience (2020-2023). Primary outcomes were peri-operative mortality and cerebrovascular morbidity. RESULTS: Thirty patients were included (63.3% males, mean age 69.8±9.6 years); 21.4% presented with aortic ruptures. Aortic aneurysm involving the aortic arch was the most frequent pathology (53.3%). Forty target vessels (TVs) were revascularized, including 19 left subclavian arteries (47.5%) and 17 left common carotid arteries (42.5%). Double fenestrations were performed in 10 patients. The proximal landing zone was Ishimaru zone 0 in 5 patients (16.7%) and zone 1 in 13 patients (43.3%). Technical success was 93%. No spinal cord ischemia was recorded, and 3 patients (10%) suffered a post-operative stroke, of which 1 was major (3.3%). The median follow-up was 12 months (range=1-48 months). Thirty-day and follow-up mortality rates were 13.5% and 15.3%, respectively. Target vessel instability was 10%, of which 3.8% required reintervention. There was no statistically significant difference in outcomes between the early and late experience groups. CONCLUSIONS: Laser fenestration thoracic endovascular aortic repair of the aortic arch performed in experienced aortic centers is associated with low early mortality and stroke rates. It is a safe and effective therapeutic option in patients considered unfit for open repair.Clinical ImpactCustom-made devices for arch pathologies requiring urgent repair are not an option because of manufacturing delays. Off-the-shelf devices with single branch arch prostheses, and outside IFU techniques such as parallel-grafts and surgeon-modified endografts have been proposed in this setting. Another off-the-shelf alternative is in situ laser fenestration thoracic endovascular repair (LFTEVAR), which addresses many limitations of the other off-the-shelf options. Our study reports the outcomes of 30 patients treated with LFTEVAR, showing that it is a viable therapeutic option in patients considered unfit for open repair acknowledging that sufficient experience with complex endovascular aortic repair is mandatory to achieve acceptable outcomes in these high-risk patients with challenging aortic anatomies.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Nana P, Le Houérou T, Rockley M, et al. Early and Midterm Outcomes of Endovascular Aortic Arch Repair Using In Situ Laser Fenestration. J Endovasc Ther. 2024. PMID: 38409773. doi:10.1177/15266028241234497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。